Pro Medicus PMCUF Stock
Pro Medicus Price Chart
Pro Medicus PMCUF Financial and Trading Overview
| Pro Medicus stock price | 112.04 USD |
| Previous Close | 95.4 USD |
| Open | 89.5 USD |
| Bid | 107.49 USD x 10000 |
| Ask | 118.62 USD x 10000 |
| Day's Range | 89.5 - 89.5 USD |
| 52 Week Range | 74.52 - 218.25 USD |
| Volume | 100 USD |
| Avg. Volume | 449 USD |
| Market Cap | 12.26B USD |
| Beta (5Y Monthly) | 0.586 |
| PE Ratio (TTM) | 70.025 |
| EPS (TTM) | 1.6 USD |
| Forward Dividend & Yield | 0.42 (0.38%) |
| Ex-Dividend Date | February 26, 2026 |
| 1y Target Est | N/A |
PMCUF Valuation Measures
| Enterprise Value | 11.49B USD |
| Trailing P/E | 70.025 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 50.950886 |
| Price/Book (mrq) | 42.119686 |
| Enterprise Value/Revenue | 47.749 |
| Enterprise Value/EBITDA | 64.205 |
Trading Information
Pro Medicus Stock Price History
| Beta (5Y Monthly) | 0.586 |
| 52-Week Change | -36.34% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 218.25 USD |
| 52 Week Low | 74.52 USD |
| 50-Day Moving Average | 93.15 USD |
| 200-Day Moving Average | 137.48 USD |
PMCUF Share Statistics
| Avg. Volume (3 month) | 449 USD |
| Avg. Daily Volume (10-Days) | 990 USD |
| Shares Outstanding | 104.47M |
| Float | 53.01M |
| Short Ratio | N/A |
| % Held by Insiders | 49.26% |
| % Held by Institutions | 25.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.62 |
| Trailing Annual Dividend Yield | 0.64% |
| 5 Year Average Dividend Yield | 31.00% |
| Payout Ratio | 0.24530001 |
| Last Split Factor | 1002:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 97.55% |
| Operating Margin (ttm) | 72.66% |
| Gross Margin | 99.86% |
| EBITDA Margin | 74.36% |
Management Effectiveness
| Return on Assets (ttm) | 26.94% |
| Return on Equity (ttm) | 76.80% |
Income Statement
| Revenue (ttm) | 240.57M USD |
| Revenue Per Share (ttm) | 2.3 USD |
| Quarterly Revenue Growth (yoy) | 28.39% |
| Gross Profit (ttm) | 240.25M USD |
| EBITDA | 178.91M USD |
| Net Income Avi to Common (ttm) | 234.7M USD |
| Diluted EPS (ttm) | 1.6 |
| Quarterly Earnings Growth (yoy) | 230.90% |
Balance Sheet
| Total Cash (mrq) | 221.82M USD |
| Total Cash Per Share (mrq) | 2.12 USD |
| Total Debt (mrq) | 2.55M USD |
| Total Debt/Equity (mrq) | 0.66 USD |
| Current Ratio (mrq) | 6.225 |
| Book Value Per Share (mrq) | 2.660039 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 127.84M USD |
| Levered Free Cash Flow (ttm) | 102.71M USD |
Profile of Pro Medicus
| Country | United States |
| State | VIC |
| City | Richmond |
| Address | 450 Swan Street |
| ZIP | 3121 |
| Phone | 61 3 9429 8800 |
| Website | https://www.promed.com.au |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 132 |
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Q&A For Pro Medicus Stock
What is a current PMCUF stock price?
Pro Medicus PMCUF stock price today per share is 112.04 USD.
How to purchase Pro Medicus stock?
You can buy PMCUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pro Medicus?
The stock symbol or ticker of Pro Medicus is PMCUF.
Which industry does the Pro Medicus company belong to?
The Pro Medicus industry is Health Information Services.
How many shares does Pro Medicus have in circulation?
The max supply of Pro Medicus shares is 109.4M.
What is Pro Medicus Price to Earnings Ratio (PE Ratio)?
Pro Medicus PE Ratio is 70.02500000 now.
What was Pro Medicus earnings per share over the trailing 12 months (TTM)?
Pro Medicus EPS is 1.6 USD over the trailing 12 months.
Which sector does the Pro Medicus company belong to?
The Pro Medicus sector is Healthcare.